BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16848039)

  • 1. The immune system: new weapon against psoriasis.
    Johns Hopkins Med Lett Health After 50; 2006 Jul; 18(5):3, 7. PubMed ID: 16848039
    [No Abstract]   [Full Text] [Related]  

  • 2. Psoriasis: more than cosmetic.
    Bren L
    FDA Consum; 2004; 38(5):10-6. PubMed ID: 15595142
    [No Abstract]   [Full Text] [Related]  

  • 3. Overview of psoriasis: update on current and emerging treatment options.
    Leonardi CL
    Manag Care; 2003 May; 12(5 Suppl):3-9; discussion 20-1. PubMed ID: 18567143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. U.S. experience of immunomodulators in the treatment of psoriasis.
    Weller R
    Br J Dermatol; 2005 Apr; 152(4):817-8; author reply 818-9. PubMed ID: 15840131
    [No Abstract]   [Full Text] [Related]  

  • 5. Biologic agents in psoriasis.
    Lee MR; Cooper AJ
    Australas J Dermatol; 2006 Nov; 47(4):217-29; quiz 229-30. PubMed ID: 17034462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasis--pathophysiology, conventional, and alternative approaches to treatment.
    Traub M; Marshall K
    Altern Med Rev; 2007 Dec; 12(4):319-30. PubMed ID: 18069901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical effects of cost reduction measures in managed care systems for treatment of severe psoriasis.
    Yentzer BA; Yelverton CB; Simpson GL; Simpson JF; Hwang W; Balkrishnan R; Feldman SR
    Dermatol Online J; 2009 Apr; 15(4):1. PubMed ID: 19450394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapies.
    Sousa E; Isenberg D
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):563-74. PubMed ID: 19591785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New treatment options for immune-mediated hematological disorders.
    Dierickx D; De Rycke A; Vanderschueren S; Delannoy A
    Eur J Intern Med; 2008 Dec; 19(8):579-86. PubMed ID: 19046722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks of combining immunosuppressive and biological treatments in inflammatory bowel disease.
    Roblin X; Phelip JM
    Arch Intern Med; 2008 Mar; 168(6):667; author reply 667-8. PubMed ID: 18362263
    [No Abstract]   [Full Text] [Related]  

  • 11. A European perspective on the challenges of managing psoriasis.
    Saraceno R; Griffiths CE
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S81-4. PubMed ID: 16488333
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of disease-modifying agents in multiple sclerosis--by the Canadian Network of MS Clinics.
    O'Connor P; Devonshire V;
    Can J Neurol Sci; 2008 May; 35(2):127-32. PubMed ID: 18574923
    [No Abstract]   [Full Text] [Related]  

  • 13. The future of multiple sclerosis treatment.
    Cohen JA
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S55-61. PubMed ID: 19200869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis: hope for the future.
    Sullivan-Whalen M; Gilleaudeau P
    Nurs Clin North Am; 2007 Sep; 42(3):467-84, vii. PubMed ID: 17825665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide.
    Stary G; Kohrgruber N; Herneth AM; Gaiger A; Stingl G; Rieger A
    AIDS; 2008 Jun; 22(10):1232-4. PubMed ID: 18525273
    [No Abstract]   [Full Text] [Related]  

  • 16. Toward the development of rational therapies in multiple sclerosis: what is on the horizon?
    Hemmer B; Hartung HP
    Ann Neurol; 2007 Oct; 62(4):314-26. PubMed ID: 17969020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenic role of tissue-resident immune cells in psoriasis.
    Boyman O; Conrad C; Tonel G; Gilliet M; Nestle FO
    Trends Immunol; 2007 Feb; 28(2):51-7. PubMed ID: 17197238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe psoriasis treated with a new macrolide: everolimus.
    Frigerio E; Colombo MD; Franchi C; Altomare A; Garutti C; Altomare GF
    Br J Dermatol; 2007 Feb; 156(2):372-4. PubMed ID: 17223881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights and therapies for teenage psoriasis.
    Belazarian L
    Curr Opin Pediatr; 2008 Aug; 20(4):419-24. PubMed ID: 18622197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile generalized pustular psoriasis.
    Xiao T; Li B; He CD; Chen HD
    J Dermatol; 2007 Aug; 34(8):573-6. PubMed ID: 17683391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.